Event Details

The Board of Directors of Dolphin Medical Services Limited held a meeting on 14 November 2026, which commenced at 6:00 PM and concluded at 8:40 PM. The Board discussed, considered, took note, and approved the Financial Results of the Company along with the Limited Review Report for the period and Half Year ended 30.09.2026. This approval was made in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Results Summary for Half Year Ended 30.09.2026

Balance Sheet Position (Amount in ₹)

  • Total Assets: 121,908,917.68 (Previous: 104,343,004.29)
  • Non-Current Assets: 83,790,198.83 (Previous: 84,627,179.29)
  • Property, Plant & Equipment: 30,445,349.71 (Previous: 31,282,330.17)
  • Capital Work-in-Progress: 3,066,482.12 (Previous: 3,066,482.12)
  • Intangible Assets Under Development: 37,848,367.00 (Previous: 37,848,367.00)
  • Non-Current Investments: 4,100,000.00 (Previous: 4,100,000.00)
  • Loans, Non-Current: 8,195,000.00 (Previous: 8,195,000.00)
  • Other Non-Current Assets: 135,000.00 (Previous: 135,000.00)
  • Current Assets: 38,118,718.85 (Previous: 19,715,825.00)
  • Inventories: 76,550.00 (Previous: 90,620.00)
  • Trade Receivables: 27,822,468.85 (Previous: 0.00)
  • Cash & Cash Equivalents: 82,000.00 (Previous: 146,000.00)
  • Bank Balance Other Than Cash: 2,500.00 (Previous: 8,500.00)
  • Loans, Current: 10,135,200.00 (Previous: 19,470,705.00)
  • Total Equity: 101,009,222.21 (Previous: 100,813,682.82)
  • Equity Share Capital: 150,999,520.00 (Previous: 150,999,520.00)
  • Other Equity: (49,990,297.79) (Previous: (50,185,837.18))
  • Total Liabilities: 20,899,695.47 (Previous: 23,529,321.47)
  • Non-Current Liabilities: 12,004,850.00 (Previous: 14,634,476.00)
  • Borrowings, Non-Current: 6,000,000.00 (Previous: 8,664,000.00)
  • Deferred Tax Liabilities (Net): 6,004,850.00 (Previous: 5,970,476.00)
  • Current Liabilities: 8,894,845.47 (Previous: 8,894,845.47)
  • Other Current Financial Liabilities: 3,894,845.47 (Previous: 3,894,845.47)
  • Advance Received for Land: 5,000,000.00 (Previous: 5,000,000.00)

Profit and Loss Statement for Half Year Ended 30.09.2026 (Amount in ₹)

  • Revenue from Operations: 4,125,000.00 (Previous [H1 FY26]: 7,501,000.00)
  • Diagnostics & Other Allied Services: 4,125,000.00
  • Other Income: 368,000.00 (Previous: 368,000.00)
  • Total Revenue: 4,493,000.00 (Previous: 7,869,000.00)
  • Total Expenses: 4,182,306.23 (Previous: 7,256,909.72)
  • Cost of Materials Consumed: 1,070,070.00 (Previous: 989,000.00)
  • Employee Benefit Expense: 771,500.00 (Previous: 1,529,000.00)
  • Financial Costs: 43,020.00 (Previous: 95,488.31)
  • Depreciation and Amortization: 418,490.23 (Previous: 902,018.74)
  • Other Expenses: 1,879,226.00 (Previous: 3,741,402.67)
  • Profit Before Tax: 310,693.77 (Previous: 612,090.28)
  • Tax Expense: 115,154.38 (Previous: 193,517.47)
  • Current Tax: 80,780.38 (Previous: 159,143.47)
  • Deferred Tax: 34,374.00 (Previous: 34,374.00)
  • Net Profit for the Period: 195,539.39 (Previous: 418,572.81)
  • Earnings Per Share (Basic & Diluted): ₹0.01 (Previous: ₹0.03)

Cash Flow Statement for Half Year Ended 30.09.2026 (Amount in ₹)

  • Net Cash from Operating Activities: 2,546,391.15
  • Net Cash from Investing Activities: 0.00
  • Net Cash from Financing Activities: (2,664,000.00) [Primarily from repayment of borrowings]
  • Net Decrease in Cash and Cash Equivalents: (117,608.85)
  • Cash and Cash Equivalents at Period End: 84,500.32

Key Notes to Accounts

  • Share Capital: Subscribed & Paid-up Capital remains unchanged at ₹150,999,520.00 (15,099,952 equity shares of ₹10 each).
  • Major Shareholders (holding >5%): Dr. Mohan Prasad GV (12.71%, 1,918,792 shares) and Dr. Lakshmi Sudha M (8.24%, 1,244,598 shares).
  • Reserves and Surplus: Other Equity stands at (₹49,990,297.79), comprising Capital Reserve (₹3,225,000.00), Share Premium (₹23,689,704.00), and accumulated losses (₹76,905,001.79).
  • Non-Current Investments: ₹4,100,000.00, invested in Meridian Projects Limited (₹3,200,000.00) and Cosmic Fortunes India Limited (₹900,000.00).
  • Intangible Assets Under Development: ₹37,848,367.00, comprising Research & Development Expenditure (₹16,300,662.00) and Miscellaneous Expenditure (₹21,547,705.00).

Annexures

The financial results are accompanied by a Limited Review Report issued by the Statutory Auditors, Kota And Associates, Chartered Accountants (F.R. No. 020801S).